Avrobio is headquartered in Cambridge, US
Report incorrect company information
Key People/Management at Avrobio
Geoff MacKay
President & CEO
Kim Warren
Head of Operations
Chris Mason
Chief Science Officer
Deanna Petersen
Chief Business Officer
Nerissa Kreher
Chief Medical Officer
Kathryn McNaughton
SVP, Portfolio & Program Management
Report incorrect company information
Avrobio Office Locations
Avrobio has offices in Toronto and Cambridge
Cambridge, US (HQ)
One Kendall Square, Building 300, Suite 201
Toronto, CA
661 University Avenue
Report incorrect company information
Avrobio Financials and Metrics
Summary Metrics
Total Funding | $85 m |
Latest funding size | $60 m |
Time since last funding | 5 months ago |
Investors | Morningside Venture Capital, Leerink Partners, Citadel, Eventide, Brace Pharma Capital, SV Health Investors, Atlas Venture, Aisling Capital, Cormorant Asset Management, Clarus Ventures |
Avrobio's latest funding round in February 2018 was reported to be $60 m. In total, Avrobio has raised $85 m
Report incorrect company information
Avrobio News and Updates
June 12, 2018
Avrobio Aims For $75 Million U.S. IPO
Report incorrect company information